ERF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eurofins Scientific SE

Watchlist Manager

Watchlist

Price: 66.76 EUR -5.41%

Market Cap: €11.7B

	Eurofins Scientific SE PAR:ERF	LU
	Cosmo Pharmaceuticals NV F:C43	IE
N	Nokia Oyj F:NOAA	FI
	Ford Otomotiv Sanayi AS F:FO9A	TR
	Gr Sarantis SA OTC:SRTSF	GR
	InPlay Oil Corp OTC:IPOOD	CA
C	Carlisle Companies Inc F:CLE	US
	Eupraxia Pharmaceuticals Inc NASDAQ:EPRX	CA
D	Dr Martens PLC OTC:DRMTY	UK
A	Asahi Group Holdings Ltd DUS:ABW	JP

Profitability Summary

Eurofins Scientific SE's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

21%

Gross Margin is Increasing

20% > 21%

Healthy Operating Margin

11%

Sustainable 3Y Average Operating Margin

12%

Declining Operating Margin

13% > 11%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

6% > 6%

Exceptional Free Cash Flow Margin

12%

Sustainable 3Y Average Free Cash Flow Margin

10%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.